Skip to content

Links

Remember Why We Are Doing All This

Meet Kyle Bryant On our next episode of Improbable Developments we welcome Kyle Bryant of the Friedreich’s Ataxia Research Alliance (FARA) to discuss his journey as a patient with Friedreich’s Ataxia (FA), as an active patient leader, and in his job as a liaison between the FA community and researchers. After being diagnosed with FA…

Read More

Final Installment of Open Water Sets Sail

The fourth module in our series on Decision Making in Pharmaceutical Research and Development. focuses on the decisions required for Phase 1 Clinical Studies. The stakes are higher as people participate in the studies. These first studies establish a beachhead that will allow the team to learn more and more about the compound. It gets pretty exciting!

Read More